deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
REYKJAVIK, Iceland, June 29 /PRNewswire-FirstCall/ -- A discovery by
scientists at deCODE genetics (Nasdaq: DCGN ) and academic colleagues from
Iceland, the Netherlands and Denmark has pointed to a common biological
mechanism contributing to both kidney stones and decreased bone mineral
densi...
Matrix Genomics, Elizabeth Corder, PhD - Gene Variation in the LRRK2 Gene and High Risk for Parkinson's Disease
Researchers at the National Institute on Aging, University College London, and Matrix Genomics, Inc. have identified a concise genetic signature found among a third of Parkinson's disease (PD) patients - but at very low frequency in the general population. The signature is found in the LRRK2 gene...
Serial Monitoring With ImmuKnow(R) is Useful in the Risk Assessment of Kidney Transplant Recipients
The results of this study will be presented during the American Transplant Congress in Boston, MA May 30 - June 3, 2009
COLUMBIA, Md., May 30 /PRNewswire/ -- Lead investigator, Dr. Manuel R. Carreno, along with his colleagues from the University of Miami , evaluated whether single or serial...
New Survey Reveals Gap in Understanding of Alzheimer's Disease Risk and Prevention Among Most Vulnerable Populations
Research presented to the 2009 Congressional Black Caucus Spring Health Braintrust finds African American and Hispanic adults are misinformed about Alzheimer's but support a screening test
WOODCLIFF LAKE, N.J., May 4 /PRNewswire/ -- African American and Hispanic adults are more concerned abou...
Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young
NEW YORK, April 23 /PRNewswire/ -- Government and private insurers are placing unprecedented pressures on Life Sciences companies to demonstrate value for the products they develop, according to The 2009 Ernst & Young business
risk report, Life sciences. Insurers, governments and individuals a...
deCODE and Celera Partner to Expand use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
REYKJAVIK, Iceland, and ALAMEDA, California, April 23
/PRNewswire-FirstCall/ -- deCODE genetics (NASDAQ: DCGN ) and Celera
Corporation (NASDAQ: CRA ) today announced the signing of agreements under
which deCODE has granted Celera non-exclusive worldwide licenses to deCODE's
genetic markers f...
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients
Next Generation Pro-Healing Technology Developments Unveiled
SEOUL, South Korea, April 22 /PRNewswire/ -- OrbusNeich's pro-healing stent technology was featured at a symposium during Angioplasty Summit TCT Asia Pacific 2009 at the Convention Center of Sheraton Grande Walkerhill Hotel in Seoul...
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Large Cardiovascular Outcomes Study To Be Initiated
Manufacturing Comparability Analysis Complete: Exenatide Once Weekly NDA Submission Remains On Track
SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., March 26 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc., (Nasdaq: AMLN ), El...
Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test
ApoAI and apoB/apoAI ratio now available with VAP Cholesterol Test at no additional cost
BIRMINGHAM, Ala., March 10 /PRNewswire/ -- Atherotech, Inc., a cardio-diagnostic company, today announced the addition of apolipoprotein A (apoAI) to its VAP(R) Cholesterol Test. The VAP (Vertical Auto Pr...
The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment
Driving to Reduce the Risks of DVT to Mark U.S. House of Representatives National Screening
NEW YORK, March 10 /PRNewswire/ -- The Coalition to Prevent DVT today announced the launch of its first nationwide tour to raise public awareness about deep-vein thrombosis (DVT) and to encourage dial...
VAP Test Demonstrates Value of Fish Oil in Reducing Heart Risk for Super Bowl Champs
Advanced cholesterol test helps usher in new era of specialized test for cardiac
risk assessment
BIRMINGHAM, Ala., Feb. 19 /PRNewswire/ -- For the Pittsburgh Steelers, adding a heart-healthy supplement to their diet may have given them the boost to win Super Bowl XLIII. That's according t...
deCODE Discovers First Genetic Variant Conferring Increased Risk of Essential Tremor
REYKJAVIK, Iceland, February 2 /PRNewswire-FirstCall/ --
Scientists from deCODE genetics (Nasdaq: DCGN ) today report the discovery
of the first variation in the sequence of the human genome ever shown to
confer increased
risk of essential tremor. The single-letter variant (or SNP)
was...
Traditional Risk Factors Often Miss Heart Disease Warning Signs
VAP(R) Cholesterol Test helps physicians identify emerging
risk factors better than standard cholesterol test and traditional
risk factors, study shows
BIRMINGHAM, Ala., Jan. 30 /PRNewswire/ -- Traditional
risk factors such as age, standard cholesterol levels and blood pressure do a poor jo...
The Risk Management and Patient Safety Institute Announces Winter and Spring 2009 Audio Program Lineup, Annual Conference Dates
LANSING, Mich., Jan. 12 /PRNewswire/ -- The
Risk Management and Patient
Safety Institute (RM&PSI) today announced its winter and spring 2009 audio
program calendar. The RM&PSI ( http://www.rmpsi.com ), a subsidiary of FinCor
Holdings Inc. ( http://www.fincorholdings.com ), is a nation...
Managing Risk Through Quality: Ansell Healthcare's Innovative Gammex(R) Glove Range on Display at Arab Health 2009
BRUSSELS, January 7 /PRNewswire/ --
- Most Comprehensive Medical Glove Offering in the Middle-East
Ansell Healthcare, a global leader in barrier protective solutions having
a 114-year history of R&D, will be showcasing the most recent offerings at
the Arab Health fair in Duba...
deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis
REYKJAVIK, Iceland, December 15 /PRNewswire-FirstCall/ --
- Findings Point to Potential Therapeutic Pathways and Provide Widening
Basis for the Development of a
Risk Assessment Test
Scientists from deCODE genetics (Nasdaq: DCGN ) and colleagues from
Australia and Denmark today rep...
Panel blasts federal nanotech risk research strategy
Washington, DC A National Research Council (NRC) committee today issued a highly critical report describing serious shortfalls in the Bush administration's strategy to better understand the environment, health and safety (EHS) risks of nanotechnology and to effectively manage those potential risk...
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service
REYKJAVIK, Iceland, Dec. 8 /PRNewswire-FirstCall/ -- deCODE genetics
(Nasdaq: DCGN ) today announced the discovery by an international consortium of
scientists from deCODE and major European and US academic institutions of a
single letter variation in the human genome (SNP) that is associated wi...
Cutting the cord to determine babies' health risk from toxic exposure
Despite the well-known dangers of first- and secondhand smoke, an estimated ten percent of pregnant women in the U.S. are smokers. Exposure of a developing baby to harmful cigarette byproducts from mothers who smoke affects an estimated 420,000 newborns each year and poses a significant health ca...
Major Independent Study Underscores Utility of deCODE MI(TM) for Better Predicting Risk of Heart Attack, Informing Statin Therapy
REYKJAVIK, Iceland, Nov. 11 /PRNewswire-FirstCall/ -- In a presentation
today at the American Heart Association Scientific Sessions 2008,
clinicians and researchers from Baylor College of Medicine have presented
data from the Atherosclerosis
Risk in Communities (ARIC) study,
demonstrating that...
ScienceBased Health Announces the Launch of Diavis(TM), a New Dietary Supplement for the 81 Million Americans With or at Risk for Diabetes
ATLANTA, Nov. 10 /PRNewswire/ -- The American Academy of Ophthalmology
(AAO) 2008 Annual Meeting -- ScienceBased Health, a leading provider of
premium nutraceuticals for eye health, today announced the launch of
DiaVis, a specialized dietary supplement to support the visual and overall
health ...
Unique New Initiative by World-Recognized Specialists in Heart Disease and Diabetes to Reduce Residual Vascular Risk Launched Today
NEW ORLEANS and LOS ANGELES, November 10 /PRNewswire/ --
- Current Treatment Fails to Abolish Majority of Vascular Risk
- Residual
Risk Reduction Initiative (R3i) Calls for Action to Reduce
the Lipid-Related Residual Vascular
Risk Unaddressed by Current Standards
of Care in Millions of Pat...
Media Alert From Residual Risk Reduction Initiative (R3i): 19:00 CST Sunday 9 November 2008
NEW ORLEANS, Louisiana, November 7 /PRNewswire/ --
- Residual Vascular
Risk Reduction: The Global Call to Action
- Announcement of the Launch of the Residual
Risk Reduction Initiative:
R3i
KEY FACTS:
Residual
Risk Reduction Initiative (R3i) calls for action to reduce the
lipid related ...
Osteoporosis Drugs Increase Risk for Heart Problems
Irregular Heartbeat Is Side Effect of Common Osteoporosis Medications
PHILADELPHIA, Oct. 27 /PRNewswire/ -- People who take bisphosphonates
for osteoporosis may be at
risk for serious atrial fibrillation (AF), or
irregular heartbeats, according to a new study. The research, presented at
CHEST...
High-Dose Zevalin(R) With Tandem Stem Cell Infusion Produces 87 Percent Overall Survival in Relapsed/Refractory or High Risk Non-Hodgkin's Lymphoma
Novel Outpatient Regimen Pioneered by Investigators from Tumor Institute in Milan
SEATTLE, Oct. 20 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
(CTI) (Nasdaq and MTA: CTIC) announced today that the Journal of Clinical
Oncology has published the results of an ...
deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
Latest discoveries add to understanding of individual
risk of basal
cell carcinoma, and are integrated into the deCODEme(TM) personal genome
analysis scan
REYKJAVIK, Iceland, Oct. 13 /PRNewswire-FirstCall/ -- Scientists at
deCODE genetics (Nasdaq: DCGN ) today report the discovery of common...
World Sight Day - Britons at Risk of Losing Their Sight by Not Having Regular Eye Tests
Glaucoma Leading Cause of Preventable Blindness in the UK(1) Though Awareness of Symptoms and
Risk Factors Remains Low
WALTON OAKS, England, October 9 /PRNewswire/ -- Today on World Sight
Day leading experts aim to raise awareness of the eye disease glaucoma. It
is estimated that t...
diaDexus, Inc. and Living Heart Foundation Offer the PLAC(R) Test to Detect Hidden Risk for Heart Attack and Stroke in Retired NFL Players
SOUTH SAN FRANCISCO, CALIF., Sept. 29 /PRNewswire/ -- diaDexus, Inc.
today announced its partnership with the Living Heart Foundation (LHF), a
non-profit organization dedicated to combating cardiovascular disease in
current and retired NFL players. The PLAC(R) Test will be included as part
of ...
Global Study Shows That Majority of Women with Osteoporosis Do Not Consider Themselves at Higher Risk for Fractures
Study of More Than 60,000 Women Underscores Need for Better Understanding of Implications and Risks Associated with Osteoporosis
MONTREAL, Sept. 15 /PRNewswire/ -- Results from the Global Longitudinal
study of Osteoporosis in Women (GLOW) showed that 55 percent of women
diagnosed with o...
WolfPAC(sm) Integrated Risk Management Announces 100th Sale
BOSTON, Sept. 8 /PRNewswire/ -- Daniel P. DeVasto, CPA, President and
Chief Executive Officer of Wolf & Company, P.C., Certified Public
Accountants and Business Consultants, is pleased to announce that the Firm
has successfully sold its 100th WolfPAC(sm)
risk assessment module.
WolfPAC(sm) I...
Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
Parents of students with known allergies are urged to put auto-injectable epinephrine at the top of the school supplies list
SILVER SPRING, Md., Aug. 27 /PRNewswire/ -- A new survey conducted by
the National Association of School Nurses (NASN) found that 72% of school
nurses have stud...
Hutchinson Center Receives $7.6 Million Federal Grant to Study How Genetic Variations Influence Risk of Common Diseases
SEATTLE, July 17 /PRNewswire/ -- Researchers at Fred Hutchinson Cancer
Research Center have received a $7.6 million, four-year grant from the
National Human Genome Research Institute to better understand the genetic
and biological roots of common diseases. The Hutchinson Center is one of
four ...
Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines
SOUTH SAN FRANCISCO, Calif., June 23 /PRNewswire/ -- diaDexus, Inc.
today announced the release of a supplement to The American Journal of
Cardiology, Vol. 101, No 12A June 16, 2008 that includes an expert
consensus panel recommendation to include testing for
lipoprotein-associated phospholipa...
HemoCue Receives First FDA CLIA Waiver in Diagnostics Industry for Quantitative Point-of-Care Test for Microalbuminuria, a Kidney and Cardiovascular Disease Risk Marker
MADISON, N.J., June 18 /PRNewswire-FirstCall/ -- HemoCue(R) AB, a
global point-of-care diagnostic test manufacturer and wholly owned
subsidiary of Quest Diagnostics Incorporated (NYSE: DGX ), today announced
that its HemoCue Albumin 201 System is the first quantitative point-of-care
test for ...
Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test
A Powerful New Tool for Early Identification of High
Risk Patients Early Intervention Can Help Prevent Disease Progression
SAN FRANCISCO, June 7 /PRNewswire/ -- Tethys Bioscience, Inc. announced
today at the 68th Scientific Sessions of the American Diabetes Association
(ADA) that it ...
PreViser and Oral Health Innovations Ltd Form UK Partnership to Provide Oral Health Scoring and Risk Analysis
MOUNT VERNON, Wash., May 20 /PRNewswire/ -- PreViser Corporation
( http://www.previser.com ), a Washington State-based provider of patented
oral disease and
risk assessment technology to the dental profession,
announced today the finalization of a licensing agreement with Oral Health
Innovatio...
RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children
RICHMOND, Va., April 29 /PRNewswire/ -- RediClinic LLC announced today
that it is teaming up with BIOSAFE Laboratories, Inc. and Glycemion, Inc.
to provide free diabetes screenings to school age children in the greater
Richmond, Va. area to help identify diabetic and pre-diabetic children and
...
deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
Markers will form the basis of a DNA diagnostic test to identify women who
may benefit from more intensive screening; latest findings folded into deCODEme(TM)
REYKJAVIK, Iceland, April 27 /PRNewswire-FirstCall/ -- Scientists from
deCODE genetics (Nasdaq: DCGN ) ...
Atherotech VAP Cholesterol Test Meets Updated ADA, ACC Measurement and Treatment Guidelines for High Risk Patients
LDL, Non-HDL and apoB measurement helps physicians guide therapy for cardiometabolic
risk patients
BIRMINGHAM, Ala., April 22 /PRNewswire/ -- The determination of LDL,
non-HDL and apoB are now recognized as valid, accurate and recommended
methods of guiding and achieving ...
Europe spends nearly twice as much as US on nanotech risk research
Washington, DC A new analysis by the Project on Emerging Nanotechnologies (PEN) indicates that European nations are investing nearly twice as much as the U.S. in research primarily aimed at addressing the potential risks of nanotechnology. The analysis also highlights a substantial over-inflation...